Inspire Medical Systems (INSP) Gross Margin (2017 - 2026)

Inspire Medical Systems has disclosed Gross Margin across 10 years of filings, most recently posting 86.47% for Q1 2026.

• Gross Margin for Q1 2026 came in at 86.47%, up 173.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 85.78% (up 112.0% YoY), and the FY2025 annual result was 85.39%, up 71.0% from the prior year.
• Gross Margin came in at 86.47% for Q1 2026 at Inspire Medical Systems, roughly flat from 86.59% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 86.59% in Q4 2025 to a low of 81.88% in Q3 2022.
• The 5-year median for Gross Margin is 84.75% (2025), against an average of 84.72%.
• Across the five-year window, Gross Margin tumbled 414 bps in 2022 and surged 222 bps in 2023, its largest moves.
• Inspire Medical Systems' Gross Margin stood at 83.94% in 2022, then increased by 2 bps to 85.43% in 2023, then retreated by 1 bps to 84.99% in 2024, then rose by 2 bps to 86.59% in 2025, then fell by 0 bps to 86.47% in 2026.
• The last three Gross Margin figures came in at 86.47% (Q1 2026), 86.59% (Q4 2025), and 85.85% (Q3 2025), per Business Quant data.